How SOX9 is Regulated in Disorders of Sex Development
Author Information
Author(s): Kevin C. Knower, Sabine Kelly, Louisa M. Ludbrook, Stefan Bagheri-Fam, Helena Sim, Pascal Bernard, Ryohei Sekido, Robin Lovell-Badge, Vincent R. Harley
Primary Institution: Molecular Genetics and Development, Prince Henry's Institute, Melbourne, Victoria, Australia
Hypothesis
How do mutations in SRY, SOX9, and SF1 affect the regulation of SOX9 in human sex determination?
Conclusion
The study shows that mutations in SRY, SOX9, and SF1 lead to a common failure to upregulate SOX9 transcription, which is crucial for proper gonadal development.
Supporting Evidence
- Mutations in SRY, SOX9, and SF1 were analyzed from individuals with 46,XY disorders of sex development.
- SRY was shown to upregulate SOX9 expression in the NT2/D1 cell line.
- Mutant proteins exhibited reduced ability to activate the human SOX9 enhancer.
Takeaway
This study helps us understand how certain genes work together to determine if a baby will be a boy or a girl, and what happens when those genes don't work right.
Methodology
The study used a human embryonal carcinoma cell line (NT2/D1) to model sex determination events and analyzed the effects of SRY, SF1, and SOX9 on the activation of the human SOX9 enhancer.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
The study analyzed mutations from thirteen individuals with 46,XY disorders of sex development.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website